Farmacoeconomia dei COXIB nella patologia osteoarticolare: revisione della letteratura
A new class of anti-inflammatory agents, the selective inhibitors of cyclooxygenase-2 (COXIBs), has been recently introduced into the market for the treatment of osteoarthritis and reumatoid arthritis. Randomized and controlled clinical trials showed a similar efficacy and a better tolerability prof...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2003-05-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1032 |